Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 345

1.

Magic-BLAST, an accurate RNA-seq aligner for long and short reads.

Boratyn GM, Thierry-Mieg J, Thierry-Mieg D, Busby B, Madden TL.

BMC Bioinformatics. 2019 Jul 25;20(1):405. doi: 10.1186/s12859-019-2996-x.

2.

Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.

Madden T, Paul R, Maddipati R, Buckel C, Goodman M, Peipert JF.

Contraception. 2019 Sep;100(3):196-201. doi: 10.1016/j.contraception.2019.05.009. Epub 2019 May 24.

PMID:
31132346
3.

Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques.

Pardi N, LaBranche CC, Ferrari G, Cain DW, Tombácz I, Parks RJ, Muramatsu H, Mui BL, Tam YK, Karikó K, Polacino P, Barbosa CJ, Madden TD, Hope MJ, Haynes BF, Montefiori DC, Hu SL, Weissman D.

Mol Ther Nucleic Acids. 2019 Apr 15;15:36-47. doi: 10.1016/j.omtn.2019.03.003. Epub 2019 Mar 21.

4.

Impact of spot size variations on dose in scanned proton beam therapy.

Kraan AC, Depauw N, Clasie B, Madden T, Kooy HM.

Phys Med. 2019 Jan;57:58-64. doi: 10.1016/j.ejmp.2018.12.011. Epub 2018 Dec 21.

PMID:
30738532
5.

Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.

Buckel C, Maddipati R, Goodman M, Peipert JF, Madden T.

Contraception. 2019 Apr;99(4):222-227. doi: 10.1016/j.contraception.2018.12.005. Epub 2019 Jan 24.

PMID:
30685287
6.

Toxicity Evaluation of a Novel Magnetic Resonance Imaging Marker, CoCl2-N-Acetylcysteine, in Rats.

Wang L, Gagea M, Martirosyan K, Johansen M, Madden T, Norberg L, Culotta KS, Frank SJ.

J Toxicol. 2018 Dec 2;2018:9173452. doi: 10.1155/2018/9173452. eCollection 2018.

7.

Reply to the paper: Misunderstood parameters of NCBI BLAST impacts the correctness of bioinformatics workflows.

Madden TL, Busby B, Ye J.

Bioinformatics. 2019 Aug 1;35(15):2699-2700. doi: 10.1093/bioinformatics/bty1026. No abstract available.

8.

Database resources of the National Center for Biotechnology Information.

Sayers EW, Agarwala R, Bolton EE, Brister JR, Canese K, Clark K, Connor R, Fiorini N, Funk K, Hefferon T, Holmes JB, Kim S, Kimchi A, Kitts PA, Lathrop S, Lu Z, Madden TL, Marchler-Bauer A, Phan L, Schneider VA, Schoch CL, Pruitt KD, Ostell J.

Nucleic Acids Res. 2019 Jan 8;47(D1):D23-D28. doi: 10.1093/nar/gky1069.

9.

PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake.

Parhiz H, Shuvaev VV, Pardi N, Khoshnejad M, Kiseleva RY, Brenner JS, Uhler T, Tuyishime S, Mui BL, Tam YK, Madden TD, Hope MJ, Weissman D, Muzykantov VR.

J Control Release. 2018 Dec 10;291:106-115. doi: 10.1016/j.jconrel.2018.10.015. Epub 2018 Oct 15.

10.

Medicaid savings from the Contraceptive CHOICE Project: a cost-savings analysis.

Madden T, Barker AR, Huntzberry K, Secura GM, Peipert JF, McBride TD.

Am J Obstet Gynecol. 2018 Dec;219(6):595.e1-595.e11. doi: 10.1016/j.ajog.2018.08.043. Epub 2018 Sep 5.

PMID:
30194049
11.

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies.

Pardi N, Parkhouse K, Kirkpatrick E, McMahon M, Zost SJ, Mui BL, Tam YK, Karikó K, Barbosa CJ, Madden TD, Hope MJ, Krammer F, Hensley SE, Weissman D.

Nat Commun. 2018 Aug 22;9(1):3361. doi: 10.1038/s41467-018-05482-0.

12.

Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial.

Zigler RE, Madden T, Ashby C, Wan L, McNicholas C.

Obstet Gynecol. 2018 Oct;132(4):888-894. doi: 10.1097/AOG.0000000000002810.

PMID:
30130351
13.

Numerical investigation of pulsed gas amplifiers operating in hollow-core optical fibers.

Lane RA, Madden TJ.

Opt Express. 2018 Jun 11;26(12):15693-15704. doi: 10.1364/OE.26.015693.

PMID:
30114827
14.

Scientific abstracts featured research at the 2018 North American Forum on Family Planning.

Teal S, Borrero S, Hubacher D, Madden T, Raine-Bennett T.

Contraception. 2018 Oct;98(4):329-330. doi: 10.1016/j.contraception.2018.07.007. Epub 2018 Jul 19. No abstract available.

PMID:
30031790
15.

Reactive Oxygen Species Generation in Human Cells by a Novel Magnetic Resonance Imaging Contrast Agent.

Wang L, Lin E, Johansen MJ, Madden T, Felix E, Martirosyan KS, Frank SJ.

J Toxicol. 2018 Mar 26;2018:6362426. doi: 10.1155/2018/6362426. eCollection 2018.

16.

Comparison of an additional early visit to routine postpartum care on initiation of long-acting reversible contraception: A randomized trial.

Bernard C, Wan L, Peipert JF, Madden T.

Contraception. 2018 Sep;98(3):223-227. doi: 10.1016/j.contraception.2018.05.010. Epub 2018 May 18.

PMID:
29778586
17.

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

Pardi N, Hogan MJ, Naradikian MS, Parkhouse K, Cain DW, Jones L, Moody MA, Verkerke HP, Myles A, Willis E, LaBranche CC, Montefiori DC, Lobby JL, Saunders KO, Liao HX, Korber BT, Sutherland LL, Scearce RM, Hraber PT, Tombácz I, Muramatsu H, Ni H, Balikov DA, Li C, Mui BL, Tam YK, Krammer F, Karikó K, Polacino P, Eisenlohr LC, Madden TD, Hope MJ, Lewis MG, Lee KK, Hu SL, Hensley SE, Cancro MP, Haynes BF, Weissman D.

J Exp Med. 2018 Jun 4;215(6):1571-1588. doi: 10.1084/jem.20171450. Epub 2018 May 8.

18.

Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN).

Hurt CN, Jones S, Madden TA, Fiander A, Nordin AJ, Naik R, Powell N, Carucci M, Tristram A.

BJOG. 2018 Aug;125(9):1171-1177. doi: 10.1111/1471-0528.15124. Epub 2018 Feb 9.

19.

Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines.

Lutz J, Lazzaro S, Habbeddine M, Schmidt KE, Baumhof P, Mui BL, Tam YK, Madden TD, Hope MJ, Heidenreich R, Fotin-Mleczek M.

NPJ Vaccines. 2017 Oct 19;2:29. doi: 10.1038/s41541-017-0032-6. eCollection 2017.

20.

Barriers and facilitators to implementing a patient-centered model of contraceptive provision in community health centers.

Politi MC, Estlund A, Milne A, Buckel CM, Peipert JF, Madden T.

Contracept Reprod Med. 2016 Nov 8;1:21. doi: 10.1186/s40834-016-0032-3. eCollection 2016.

21.

Effects of spot parameters in pencil beam scanning treatment planning.

Kraan AC, Depauw N, Clasie B, Giunta M, Madden T, Kooy HM.

Med Phys. 2018 Jan;45(1):60-73. doi: 10.1002/mp.12675. Epub 2017 Dec 10.

PMID:
29148575
22.

Impact of spot charge inaccuracies in IMPT treatments.

Kraan AC, Depauw N, Clasie B, Giunta M, Madden T, Kooy HM.

Med Phys. 2017 Aug;44(8):3923-3931. doi: 10.1002/mp.12390. Epub 2017 Jul 14.

PMID:
28569997
23.
24.

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.

Pardi N, Secreto AJ, Shan X, Debonera F, Glover J, Yi Y, Muramatsu H, Ni H, Mui BL, Tam YK, Shaheen F, Collman RG, Karikó K, Danet-Desnoyers GA, Madden TD, Hope MJ, Weissman D.

Nat Commun. 2017 Mar 2;8:14630. doi: 10.1038/ncomms14630.

25.

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.

Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, Wagner W, Granados A, Greenhouse J, Walker M, Willis E, Yu JS, McGee CE, Sempowski GD, Mui BL, Tam YK, Huang YJ, Vanlandingham D, Holmes VM, Balachandran H, Sahu S, Lifton M, Higgs S, Hensley SE, Madden TD, Hope MJ, Karikó K, Santra S, Graham BS, Lewis MG, Pierson TC, Haynes BF, Weissman D.

Nature. 2017 Mar 9;543(7644):248-251. doi: 10.1038/nature21428. Epub 2017 Feb 2.

26.

Access to mindfulness.

Madden TA.

J R Soc Med. 2017 Jan;110(1):4. doi: 10.1177/0141076816666434. No abstract available.

PMID:
28106488
27.

Management of Dentin Hypersensitivity by National Dental Practice-Based Research Network practitioners: results from a questionnaire administered prior to initiation of a clinical study on this topic.

Kopycka-Kedzierawski DT, Meyerowitz C, Litaker MS, Chonowski S, Heft MW, Gordan VV, Yardic RL, Madden TE, Reyes SC, Gilbert GH; National Dental PBRN Collaborative Group.

BMC Oral Health. 2017 Jan 13;17(1):41. doi: 10.1186/s12903-017-0334-0.

28.

Changes in body composition in women using long-acting reversible contraception.

Silva Dos Santos PN, Madden T, Omvig K, Peipert JF.

Contraception. 2017 Apr;95(4):382-389. doi: 10.1016/j.contraception.2016.12.006. Epub 2016 Dec 30.

29.

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.

Andersson BS, Thall PF, Valdez BC, Milton DR, Al-Atrash G, Chen J, Gulbis A, Chu D, Martinez C, Parmar S, Popat U, Nieto Y, Kebriaei P, Alousi A, de Lima M, Rondon G, Meng QH, Myers A, Kawedia J, Worth LL, Fernandez-Vina M, Madden T, Shpall EJ, Jones RB, Champlin RE.

Bone Marrow Transplant. 2017 Apr;52(4):580-587. doi: 10.1038/bmt.2016.322. Epub 2016 Dec 19.

30.

Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.

Mejia M, McNicholas C, Madden T, Peipert JF.

Contraception. 2016 Nov;94(5):556-560. doi: 10.1016/j.contraception.2016.06.013. Epub 2016 Jun 27.

31.

Pieter Cullis' quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?

Tam YK, Madden TD, Hope MJ.

J Drug Target. 2016 Nov;24(9):774-779. Epub 2016 Sep 2. Review.

PMID:
27588674
32.

Theoretical and numerical treatment of modal instability in high-power core and cladding-pumped Raman fiber amplifiers.

Naderi S, Dajani I, Grosek J, Madden T.

Opt Express. 2016 Jul 25;24(15):16550-65. doi: 10.1364/OE.24.016550.

PMID:
27464110
33.

In Reply.

Politi MC, Sonfield A, Madden T.

JAMA. 2016 Jun 28;315(24):2735-6. No abstract available.

PMID:
27390800
34.

Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy.

Moteabbed M, Yock TI, Depauw N, Madden TM, Kooy HM, Paganetti H.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):190-8. doi: 10.1016/j.ijrobp.2015.12.368. Epub 2015 Dec 29.

35.

Addressing Challenges to Implementation of the Contraceptive Coverage Guarantee of the Affordable Care Act.

Politi MC, Sonfield A, Madden T.

JAMA. 2016 Feb 16;315(7):653-4. doi: 10.1001/jama.2016.0204. No abstract available.

PMID:
26832953
36.

Accuracy of information about the intrauterine device on the Internet.

Madden T, Cortez S, Kuzemchak M, Kaphingst KA, Politi MC.

Am J Obstet Gynecol. 2016 Apr;214(4):499.e1-499.e6. doi: 10.1016/j.ajog.2015.10.928. Epub 2015 Nov 4.

37.

Long-term utilization and continuation of intrauterine devices.

Diedrich JT, Madden T, Zhao Q, Peipert JF.

Am J Obstet Gynecol. 2015 Dec;213(6):822.e1-6. doi: 10.1016/j.ajog.2015.08.077. Epub 2015 Sep 25.

38.

Contraception and Pregnancy Planning in Women With Congenital Heart Disease.

Lindley KJ, Conner SN, Cahill AG, Madden T.

Curr Treat Options Cardiovasc Med. 2015 Nov;17(11):50. doi: 10.1007/s11936-015-0413-y.

PMID:
26403241
39.

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.

Pardi N, Tuyishime S, Muramatsu H, Kariko K, Mui BL, Tam YK, Madden TD, Hope MJ, Weissman D.

J Control Release. 2015 Nov 10;217:345-51. doi: 10.1016/j.jconrel.2015.08.007. Epub 2015 Aug 8.

40.

Three-year continuation of reversible contraception.

Diedrich JT, Zhao Q, Madden T, Secura GM, Peipert JF.

Am J Obstet Gynecol. 2015 Nov;213(5):662.e1-8. doi: 10.1016/j.ajog.2015.08.001. Epub 2015 Aug 7.

41.

Contraceptive Use and Unintended Pregnancy in Women With Congenital Heart Disease.

Lindley KJ, Madden T, Cahill AG, Ludbrook PA, Billadello JJ.

Obstet Gynecol. 2015 Aug;126(2):363-9. doi: 10.1097/AOG.0000000000000911.

PMID:
26241427
42.

Adolescent Experiences With Intrauterine Devices: A Qualitative Study.

Schmidt EO, James A, Curran KM, Peipert JF, Madden T.

J Adolesc Health. 2015 Oct;57(4):381-6. doi: 10.1016/j.jadohealth.2015.05.001. Epub 2015 Jun 27.

43.

Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion.

Grentzer JM, Peipert JF, Zhao Q, McNicholas C, Secura GM, Madden T.

Contraception. 2015 Oct;92(4):313-8. doi: 10.1016/j.contraception.2015.06.012. Epub 2015 Jun 17.

44.

Positive Testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease in IUD Users.

Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF.

J Womens Health (Larchmt). 2015 May;24(5):354-9. doi: 10.1089/jwh.2015.5190. Epub 2015 Apr 2.

45.

Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.

Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF.

J Womens Health (Larchmt). 2015 May;24(5):349-53. doi: 10.1089/jwh.2015.5191. Epub 2015 Mar 31.

46.

Fertility after intrauterine device removal: a pilot study.

Stoddard AM, Xu H, Madden T, Allsworth JE, Peipert JF.

Eur J Contracept Reprod Health Care. 2015 Jun;20(3):223-30. doi: 10.3109/13625187.2015.1010639. Epub 2015 Mar 9.

47.

The role of contraceptive attributes in women's contraceptive decision making.

Madden T, Secura GM, Nease RF, Politi MC, Peipert JF.

Am J Obstet Gynecol. 2015 Jul;213(1):46.e1-46.e6. doi: 10.1016/j.ajog.2015.01.051. Epub 2015 Jan 30.

48.

Maternal age and risk of labor and delivery complications.

Cavazos-Rehg PA, Krauss MJ, Spitznagel EL, Bommarito K, Madden T, Olsen MA, Subramaniam H, Peipert JF, Bierut LJ.

Matern Child Health J. 2015 Jun;19(6):1202-11. doi: 10.1007/s10995-014-1624-7.

49.

Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.

Tristram A, Hurt CN, Madden T, Powell N, Man S, Hibbitts S, Dutton P, Jones S, Nordin AJ, Naik R, Fiander A, Griffiths G.

Lancet Oncol. 2014 Nov;15(12):1361-8. doi: 10.1016/S1470-2045(14)70456-5. Epub 2014 Oct 7.

50.

The contraceptive CHOICE project round up: what we did and what we learned.

McNicholas C, Madden T, Secura G, Peipert JF.

Clin Obstet Gynecol. 2014 Dec;57(4):635-43. doi: 10.1097/GRF.0000000000000070.

Supplemental Content

Loading ...
Support Center